Lindahl acts as legal advisor when Swedencare AB (publ) acquires the US company HOLDEN2 LLC (”HOLDEN2” or the “Company”).
The purchase price for the Company amounts to approximately 178 MSEK and consists of a cash amount of approximately 125 MSEK and an issue in kind of 199,732 shares in Swedencare to the sellers upon closing, which is expected to take place on January 4, 2021.
As part of the financing of the acquisition, Swedencare has carried out a directed new share issue, through a so called Accelerated Book Building, of 750,000 shares to institutional investors. The share issue has provided the company with gross proceeds of approximately 220 MSEK.
Swedencare develops, produces, markets, and sells premium products on the global and fast-growing market for animal health products for cats, dogs and horses. Swedencare’s product groups are represented on approximately fifty markets around the world and are sold through subsidiaries in the Nordics, United States, France, Spain, Greece, Great Britain and Ireland and through an external distribution network. Swedencare’s share is listed on Nasdaq First North Growth Market with ticker SECARE.
HOLDEN2, which was founded in 2011, is dedicated to offer premium pet healthcare products through different online channels. The products, sold inter alia under the brand PetMDÒ, are offered primarily through the big online platforms Amazon and Chewy.com.
Lindahl’s team consisted of Johan Herrström, Pernilla Skoglösa, Simon Petersson, Pontus Söderberg (M&A) and Christian Sundén (IP). Lindahl was assisted in the acquisition by Wiggin and Dana in New York, a member of the same global network as Lindahl, TerraLex.